Humacyte Stock (HUMA): Why The Price Fell

By Amit Chowdhry ● Dec 30, 2021
  • The stock price of Humacyte Inc (NASDAQ: HUMA) fell in the most recent trading session. This is why it happened.

The stock price of Humacyte Inc (NASDAQ: HUMA) fell in the most recent trading session. Investors are responding negatively to what was revealed in a Form 8-K filing.

This Amendment No. 1 on Form 8-K/A amended the Current Report on Form 8-K of Humacyte, which reported the departure of Jeffrey H. Lawson, M.D., PhD. as the company’s Chief Surgical Officer and Dr. Lawson’s resignation from the board of directors, each effective as of the separation date. The Original Report contained a scrivener error and incorrectly stated the separation date as December 31, 2022. The correct separation date is actually December 31, 2021.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.